Rajeev M. Shah bought $75.1M of Septerna (SEPN)

Executed Oct 28 2024, disclosed Oct 30 2024, 2 days later.

Value, as filed

$75.1M

4,170,000 sh across 2 lots

Executed

Oct 28 2024

the trade date, as filed

Disclosed

Oct 30 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+26.9%

+8.1% from execution

Over the 21 trading sessions from the disclosed entry session (Oct 30 2024), the stock returned +26.9% (delay-adjusted); from the execution session (Oct 28 2024), +8.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

RS Rajeev M. Shah Director profile →

Rajeev M. Shah (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in VOR. The largest single filing was $13.5M of VOR (458,121 sh across 10 lots, as filed), executed Oct 15 2025.

The name

SEPN

Septerna, Inc. SEPN · Healthcare · 13 filings in 24 months ticker →

Healthcare · Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule produc…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→